Home » Topics » Conferences

Conferences
RSS

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Eisai presents novel potential antipsychotic agent

Sep. 22, 1997

Highly selective 5-HT1D agonists described by MS&D

Sep. 22, 1997

Taisho/Nihon Nohyaku evaluate thiazole derivatives as antipsychotics

Sep. 22, 1997

Eel calcitonin nasal spray evaluated in phase I

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...